Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
Novel predictive markers are needed to determine treatment efficacy in pancreatic cancer at
an early stage. Preferably, these markers could be determined non-invasively and provide
insight into the biology of pancreatic cancer. Several MR techniques can serve for this
purpose. However, optimalisation of these techniques is needed and their reproducibility
should be assessed.
Phase:
N/A
Details
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)